Literature DB >> 989270

Altered carbohydrate metabolism in breast cancer and benign breast affections.

B R Muck, S Trotnow, H Egger, G Hommel.   

Abstract

Breast diseases in 792 women were studied by biopsy and histological evaluation. In all subjects glucose tolerance was examined by OGTT (100 g glucose). The diabetes frequency of 22% in 326 women with breast cancer was compared with the frequency in women with fibroadenoma (n = 101), papilloma (n = 80), fibrocystic disease (n = 107), lipoma, granuloma, fibrosis (n = 88), papilloma with proliferation (n = 32), mastopathy with proliferation (n = 33) and carcinoma in situ lobulare (n = 11). The statistical evaluation was done with an electronic data processing system. We used matched pairs according to age, height and weight. Diabetogenic factors like age and overweight were thus allowed for. These comparative statistics showed a frequency of diabetes twice or three times higher in women with breast cancer. This result cannot be regarded as a consequence of age, overweight and menopause. In groups with fibroadenoma, fibrocystic disease and lipoma, we found glucose tolerance in 1-3%, whereas the group with proliferation (including carcinoma in situ) showed an incidence of 7%. The remarkably high incidence rate of 14% in women with papilloma can be explained by the higher age and the more frequent obesity in this collective.

Entities:  

Mesh:

Year:  1976        PMID: 989270     DOI: 10.1007/bf00667684

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  13 in total

1.  [Diabetes mellitus and carcinoma; statistical studies of 25147 sections].

Authors:  W WERNER
Journal:  Z Krebsforsch       Date:  1955

2.  A study of the epidemiology of cancer of the breast.

Authors:  E L WYNDER; I J BROSS; T HIRAYAMA
Journal:  Cancer       Date:  1960 May-Jun       Impact factor: 6.860

3.  [Endometrial carcinoma and disorder of glucose metabolism (author's transl)].

Authors:  B R Muck; S Trotnow
Journal:  Arch Gynakol       Date:  1974-05-14

4.  [Epidemiology of breast cancer].

Authors:  H K Pauli; S Trotnow
Journal:  Arch Gynakol       Date:  1973

5.  [Assessment of oral glucose tolerance].

Authors:  H Mehnert; M Haslbeck; H Förster
Journal:  Dtsch Med Wochenschr       Date:  1972-11-10       Impact factor: 0.628

6.  [Endocrine protective mechanisms against endometrial and breast cancer].

Authors:  R Kaiser
Journal:  Dtsch Med Wochenschr       Date:  1969-11-28       Impact factor: 0.628

7.  The epidemiology of breast cancer: review and prospects.

Authors:  F de Waard
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

Review 8.  Identification of high risk groups in breast cancer.

Authors:  C Zippin; N L Petrakis
Journal:  Cancer       Date:  1971-12       Impact factor: 6.860

9.  Cancer of the breast, diabetes and pathological glucose tolerance.

Authors:  B R Muck; S Trotnow; G Hommel
Journal:  Arch Gynakol       Date:  1975-12-16

10.  Metabolic parameters in women with metastatic breast cancer.

Authors:  A C Carter; B W Lefkon; M Farlin; E B Feldman
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

View more
  3 in total

1.  A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study.

Authors:  Rainer J Klement; Gabriele Schäfer; Reinhart A Sweeney
Journal:  J Tradit Complement Med       Date:  2019-03-21

2.  Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study.

Authors:  Rainer J Klement; Petra S Koebrunner; Kelley Krage; Michael M Weigel; Reinhart A Sweeney
Journal:  Med Oncol       Date:  2020-11-28       Impact factor: 3.064

3.  Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients.

Authors:  Rainer J Klement; Colin E Champ; Ulrike Kämmerer; Petra S Koebrunner; Kelley Krage; Gabriele Schäfer; M Weigel; Reinhart A Sweeney
Journal:  Breast Cancer Res       Date:  2020-08-20       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.